The short-term efficacy of combined treatments targeting B cell and plasma cell in severe and refractory Anti-N-methyl-D-aspartate receptor encephalitis: Two case reports

CNS Neurosci Ther. 2019 Jan;25(1):151-153. doi: 10.1111/cns.13078. Epub 2018 Oct 21.

Authors

Xiao-Ting Zhang^{1

2}, Chun-Juan Wang¹, Bao-Jie Wang¹, Shou-Gang Guo¹

Affiliations

¹ Shandong Provincial Hospital Affiliated to Shandong University, Jinan City, China.
² School of Clinical Medicine, Qilu Medical College, Shandong University, Jinan City, China.

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-N-Methyl-D-Aspartate Receptor Encephalitis / blood
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / drug therapy*
B-Lymphocytes / drug effects*
Bortezomib / therapeutic use
Drug Therapy, Combination
Female
Hematologic Agents / therapeutic use*
Humans
Middle Aged
Retreatment
Young Adult

Substances

Hematologic Agents
Bortezomib